Grouping mutations based on their likelihood of response to specific drug types in future EGFR TKI trials may eventually help physicians tailor treatments for patients with atypical mutations. Read more
After nearly 50 years of patient care at Rush University Medical Center, Dr. Bonomi will retire from his clinical service. Read more
Philip D. Bonomi, MD, who specializes in caring for those with lung cancer, has made many contributions to the field during his 47 years of service. Read more
Investigators at Sarah Cannon look to next-generation sequencing for molecular signatures that may correlate with response. Read more
See the latest IASLC meeting news, including an extended deadline for ACLC abstract submissions and COVID-19 guideline updates for those traveling to WCLC. Read more
Researchers say increased screening of at-risk populations, including those who have never smoked, may improve survival more than any other strategy. Read more
Aumolertinib may ultimately prove to be an alternative to osimertinib, but it faces challenges before it can win us fda approval. Read more
Evidence demonstrates superior performance of the PLCOm2012 model for identifying individuals for lung cancer screening. Read more
Study provides evidence to support the potential role of real-world data in consideration of technologies where only single-arm trial data exists. Read more
When publicly reported patient outcomes emerge, the data available to patients should paint the most complete picture possible. Read more